Babyl & Novo Nordisk partner to provide an innovative approach to diabetes awareness and care in Rwanda
Go back to Babyl & Novo Nordisk partner to provide an innovative approach to diabetes awareness and care in Rwanda| (NYSE: BBLN) | Delayed: 0.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.55 | 52 Week High | $ | |||
| Open | $0.55 | 52 Week Low | $ | |||
| Day High | $0.55 | P/E | N/A | |||
| Day Low | $0.55 | EPS | $ | |||
| Volume | 234,805 | |||||
